Barclays Maintains Overweight on Kosmos Energy, Raises Price Target to $11
Barclays analyst James Hosie maintains Kosmos Energy (NYSE:KOS) with a Overweight and raises the price target from $6.5 to $11.
Goldman Sachs Maintains Buy on Kosmos Energy, Raises Price Target to $9.5
Goldman Sachs analyst Neil Mehta maintains Kosmos Energy (NYSE:KOS) with a Buy and raises the price target from $8 to $9.5.
Barclays Maintains Overweight on Kosmos Energy, Raises Price Target to $6.5
Barclays analyst James Hosie maintains Kosmos Energy (NYSE:KOS) with a Overweight and raises the price target from $6 to $6.5.
88 Biggest Movers From Yesterday
Gainers
Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results.
55 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Enservco Corporation (NYSE: ENSV) surged 228% to $8.20 after jumping around 85% on Monday.
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
31 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Resonant Inc. (NASDAQ: RESN) jumped 249% to $4.29 after Murata Electronics announced plans to buy the company at $4.50 per share in cash.
56 Biggest Movers From Yesterday
Gainers
Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
Barclays Upgrades Kosmos Energy to Overweight
Barclays analyst James Hosie upgrades Kosmos Energy (NYSE:KOS) from Equal-Weight to Overweight.